SINGAPORE--(BUSINESS WIRE)--National Cancer Centre Singapore (NCCS), Singapore Clinical Research Institute (SCRI) and IMS Health (NYSE:IMS) will collaborate to develop its first Liver Cancer or Hepatocellular Carcinoma (HCC) Registry in Asia through the Asian HCC Physician Network.
The non-identified data from this Registry can help policymakers and health care professionals formulate strategies to manage liver cancer patients.
